

Aron Simkins, MD
171 posts

@dr_simkins
GI Med Onc | @ConquerCancerFd #ASCO21 Merit Award. @GWSMHS @GWCancer @UTHimres @McgovernMed alum 🇮🇱🇻🇪



The chants heard yesterday in the heart of the Jewish community in Kew Gardens, Queens, in support of Hamas were vile and deliberate acts of intimidation meant to terrorize our Jewish community. NYC and state elected officials must condemn this immediately and unequivocally. Anything less is a failure of leadership. Silence leads to action. We must say it loud and clear: HAMAS AND THEIR SUPPORTERS ARE NOT WELCOME HERE.














🚨 Resectable Gastric Cancer | #GI26 CRITICS-II answers a key question What is the best preoperative strategy when adjuvant therapy is omitted? 🧪 Trial design Three fully neoadjuvant approaches compared ➡️ Chemotherapy alone ➡️ Chemotherapy → Chemoradiotherapy ➡️ Chemoradiotherapy alone 🎯 Primary endpoint 1-year event-free survival Activity threshold ≥75% 📊 Key results ✅ CT → CRT: 1-yr EFS 84% | 1-yr OS 89% | pCR 20% ✅ CRT alone: 1-yr EFS 78% | better compliance | lower toxicity ❌ CT alone: 1-yr EFS 68% | lowest survival | higher toxicity 🧠 Clinical interpretation • Chemotherapy alone fails efficacy threshold • Total neoadjuvant therapy gives the best oncologic signal • CRT alone offers a toxicity-compliant alternative • CT → CRT emerges as the preferred backbone for phase III testing and organ-sparing strategies 📌 Take-home message In resectable gastric cancer, treatment intensification before surgery matters. Pure chemo upfront is no longer convincing. #OncoTwitter #MedTwitter #GastricCancer #GI26 @asco @oncoalert @Larvol






2/3 Today’s violence must be put in context. Almost six decades of hostile military rule over an entire civilian population (incomprehensibly ignored by too many official statements & media outlets) are in themselves an aggression, and the recipe for more insecurity for all.